Stereotactic Body Radiation Therapy: A New Standard Option for Pancreatic Cancer?

Restricted access

Joseph M. Herman, MD, MSc, is an Associate Professor of Radiation Oncology at The Johns Hopkins University, where he serves as Director of the Gastrointestinal Division. He is the Clinical Research Director of the Department of Radiation Oncology & Molecular Radiation Services and Co-Director of the Pancreatic Multidisciplinary Clinic at Johns Hopkins. He is the site principal investigator on several national and institutional clinical protocols involving pancreatic cancer. He is a writing committee member of the NCCN Pancreatic Adenocarcinoma Panel and American College of Radiology guidelines panels and serves on the National Institute of Health Pancreas Task Force and the medical advisory board for the Pancreatic Cancer Action Network.

The ideas and viewpoints expressed in this commentary are those of the author and do not necessarily represent any policy, position, or program of NCCN.

Albert C. Koong, MD, PhD, is a Professor of Radiation Oncology at Stanford University School of Medicine. He serves as the Associate Chair and Medical Director of Radiation Oncology Clinical Operations. His area of clinical interest is in the application of advanced radiation techniques for gastrointestinal malignancies. He is Principal Investigator for both institutional and national studies in pancreatic cancer. His current research is funded by the National Cancer Institute and the My Blue Dots Foundation. He is a member of the NCCN Pancreatic Adenocarcinoma and American College of Radiology guidelines panels.

  • 1.

    Hoyer M, Roed H, Sengelov L. Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. Radiother Oncol 2005;76:4853.

    • Search Google Scholar
    • Export Citation
  • 2.

    Schellenberg D, Goodman KA, Lee F. Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2008;72:678686.

    • Search Google Scholar
    • Export Citation
  • 3.

    Schellenberg D, Kim J, Christman-Skieller C. Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2011;81:181188.

    • Search Google Scholar
    • Export Citation
  • 4.

    Herman J, Chang D, Goodman K. A phase II multi-institutional study to evaluate gemcitabine and fractionated stereotactic body radiotherapy for unresectable, locally advanced pancreatic adenocarcinoma [abstract]. J Clin Oncol 2012;30(Suppl):Abstract 4045.

    • Search Google Scholar
    • Export Citation
  • 5.

    Mahadevan A, Jain S, Goldstein M. Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2010;78:735742.

    • Search Google Scholar
    • Export Citation
  • 6.

    Tozzi A, Comito T, Alongi F. SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience. Radiat Oncol 2013;8:148.

    • Search Google Scholar
    • Export Citation
  • 7.

    Timmerman RD, Herman J, Cho LC. Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice. J Clin Oncol 2014;32:28472854.

    • Search Google Scholar
    • Export Citation
  • 8.

    Murphy JD, Christman-Skieller C, Kim J. A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer. Int J Radiat Oncol Biol Phys 2010;78:14201426.

    • Search Google Scholar
    • Export Citation
  • 9.

    Hong TS, Ryan DP, Blaszkowsky LS. Phase I study of preoperative short-course chemoradiation with proton beam therapy and capecitabine for resectable pancreatic ductal adenocarcinoma of the head. Int J Radiat Oncol Biol Phys 2011;79:151157.

    • Search Google Scholar
    • Export Citation
  • 10.

    Hong TS, Ryan DP, Borger DR. A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma. Int J Radiat Oncol Biol Phys 2014;89:830838.

    • Search Google Scholar
    • Export Citation
  • 11.

    Chuong MD, Springett GM, Freilich JM. Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated. Int J Radiat Oncol Biol Phys 2013;86:516522.

    • Search Google Scholar
    • Export Citation
  • 12.

    Rwigema JC, Parikh SD, Heron DE. Stereotactic body radiotherapy in the treatment of advanced adenocarcinoma of the pancreas. Am J Clin Oncol 2011;34:6369.

    • Search Google Scholar
    • Export Citation
  • 13.

    Rwigema JC, Heron DE, Parikh SD. Adjuvant stereotactic body radiotherapy for resected pancreatic adenocarcinoma with close or positive margins. J Gastrointest Cancer 2012;43:7076.

    • Search Google Scholar
    • Export Citation
  • 14.

    Dholakia AS, Kumar R, Raman SP. Mapping patterns of local recurrence after pancreaticoduodenectomy for pancreatic adenocarcinoma: a new approach to adjuvant radiation field design. Int J Radiat Oncol Biol Phys 2013;87:10071015.

    • Search Google Scholar
    • Export Citation
  • 15.

    Verslype C, Van Cutsem E, Dicato M. The management of metastatic pancreatic cancer: expert discussion and recommendations from the 14th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2012. Ann Oncol 2013;24(Suppl 4):iv510.

    • Search Google Scholar
    • Export Citation
  • 16.

    Hsu CC, Wolfgang CL, Laheru DA. Early mortality risk score: identification of poor outcomes following upfront surgery for resectable pancreatic cancer. J Gastrointest Surg 2012;16:753761.

    • Search Google Scholar
    • Export Citation
  • 17.

    Von Hoff DD, Ervin T, Arena FP. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 2013;369:16911703.

    • Search Google Scholar
    • Export Citation
  • 18.

    Murphy JD, Chang DT, Abelson J. Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer. Cancer 2012;118:11191129.

    • Search Google Scholar
    • Export Citation
  • 19.

    Huguet F, Hammel P, Vernerey D. Impact of chemoradiotherapy (CRT) on local control and time without treatment in patients with locally advanced pancreatic cancer (LAPC) included in the international phase III LAP 07 study [abstract]. J Clin Oncol 2014;32(Suppl):Abstract 4001.

    • Search Google Scholar
    • Export Citation
  • 20.

    Taniguchi CM, Murphy JD, Eclov N. Dosimetric analysis of organs at risk during expiratory gating in stereotactic body radiation therapy for pancreatic cancer. Int J Radiat Oncol Biol Phys 2013;85:10901095.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 49 33 1
PDF Downloads 17 14 0
EPUB Downloads 0 0 0